Glioblastoma: Part I. Current state of affairs.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 21736079)

Published in Mo Med on July 07, 2011

Authors

Michael E Salacz1, Kenneth R Watson, David A Schomas

Author Affiliations

1: Saint Luke's Brain Tumor Center, Kansas City, MO, USA. msalacz@saint-lukes.org

Articles by these authors

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol (2007) 2.44

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.62

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg (2009) 1.51

A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol (2009) 1.16

Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg (2012) 0.96

Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years. Neuro Oncol (2013) 0.87

Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis. Am J Clin Oncol (2016) 0.80

Glioblastoma. Part II: Future directions. Mo Med (2011) 0.76

Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol (2013) 0.76

Breast conservation therapy utilizing partial breast brachytherapy for early-stage cancer of the breast: a retrospective review from the Saint Luke's Cancer Institute. Am J Clin Oncol (2015) 0.75

Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience. Am J Clin Oncol (2016) 0.75

Adult-type Langerhans cell histiocytosis: minimal treatment for maximal results. Cutis (2014) 0.75